BIOL

Biolase, Inc.
BIOL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

12 hedge funds and large institutions have $199K invested in Biolase, Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$95.4K
2
+$44.3K
3
+$19.4K
4
Walleye Capital
Walleye Capital
New York
+$5.08K
5
TRCT
Tower Research Capital (TRC)
New York
+$2.87K

Top Sellers

1
-$67K
2
-$38.5K
3
-$28.8K
4
TSS
Two Sigma Securities
New York
-$11.4K
5
PCM
Perkins Capital Management
Minnesota
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$95.4K
2
$46.5K
3
$31.5K
4
$22.5K
5
$3K
6
$93
7
$76
8
$69
9
$32
10
$15
11
$6
12
$1
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2